tirzepatide/niacinamide 17/2 mg/ml Tirzepatide is the dual-action one. Instead of working on a single hormone, it targets two — GLP-1 and GIP — which is why it tends to have a stronger effect on appetite Tirzepatide / Niacinamide Injection |

The peptide is now tethered to albumin and inherits albumin's natural 19 to 21 day plasma residence [3]

Summary Microdosing is typically treated as a tolerability-first, clinician-guided approach, involving starts below the usual 2.5 mg step, extending escalation windows from 4 to 8 weeks or more, or pausing at intermediate maintenance doses, such as 5 mg or 7.5 mg, to prioritize steady adherence and symptom control

Unfortunately, most regain two-thirds of their lost weight within a year as well as worsening of metabolic health indicators (Mozaffarian et al., 2025

But if several are present together, its worth reviewing your daily protein log and identifying where intake may be falling short

Additionally, semaglutide is not safe for pregnant and lactating females and children

Sprem M et al